<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01789307</url>
  </required_header>
  <id_info>
    <org_study_id>H12-01647</org_study_id>
    <nct_id>NCT01789307</nct_id>
  </id_info>
  <brief_title>Lactose, Sucrose &amp; Corn Syrup Tolerance</brief_title>
  <official_title>Lactose: A Unique Carbohydrate Enabling Homeostatic Regulation of Blood Glucose &amp; Insulin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lactose, one of the key nutrients in human milk may be critically important to infants for
      more reasons than being a source of energy. We are interested in understanding how lactose
      when compared to other sugars influences how nutrients, specifically macronutrients are
      handled after digestion and absorption. To date, there have been no studies looking at how
      fat and protein varies when lactose compared to other sugars is ingested. There may be
      metabolic advantages to considering lactose for nutrition support of premature infants rather
      than glucose or dextrose as is often used in intravenous feeds, or the corn syrup solids in
      lactose-free formulas. We hope the information from this study will provide new information
      on the unique aspects of lactose.

      Hypothesis: The hypothesis is that providing carbohydrate as lactose:

        1. minimizes the amount of carbohydrate that is converted into fat

        2. enables a relatively constant metabolic state throughout feeding interval that avoids
           swings of high to low insulin, glucose, and fats.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial changes in plasma insulin, glucagon, triglycerides and amino acids.</measure>
    <time_frame>6 hours</time_frame>
    <description>Area under the curve changes in the outcome measures following oral ingestion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial changes in plasma fatty acids.</measure>
    <time_frame>6 hours</time_frame>
    <description>Area under the curve analyses of changes in plasma fatty acids following oral ingestion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Focus of Study: Oral Tolerance Test With Glucose, Lactose, Sucrose</condition>
  <arm_group>
    <arm_group_label>corn syrup solids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>corn syrup solids oral ingestion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sucrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sucrose oral ingestion</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>corn syrup solids</intervention_name>
    <description>oral ingestion 50 grams, 2 doses</description>
    <arm_group_label>corn syrup solids</arm_group_label>
    <other_name>corn syrup</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>sucrose</intervention_name>
    <description>oral ingestion 50 grams, 2 doses</description>
    <arm_group_label>sucrose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male

          -  at least 19 years of age

          -  body mass index (BMI) between 18.5 and 25

          -  fasting blood glucose level &lt; 6.1 mmol/L (110 mg/dL) measured by glucometer on the day
             of the study and

          -  comfortable speaking, reading and understanding English

          -  comfortable drinking at least one cup (250 ml) of milk

          -  non-smoking

        Exclusion Criteria:

          -  not willing to provide blood samples, have

          -  impaired lactose or glucose tolerance,

          -  pre-diabetes, diabetes mellitus and any other endocrine disorder,

          -  coronary heart disease, liver function test abnormalities or any chronic disease

          -  routinely take medications, including aspirin, cyclooxygenase-2 inhibitors, statins
             and fish oil

          -  consuming more than 1 alcoholic drink per day
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheila M Innis, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia, Child &amp; Family Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Child &amp; Family Research Institute</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2012</study_first_submitted>
  <study_first_submitted_qc>February 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2013</study_first_posted>
  <last_update_submitted>July 3, 2014</last_update_submitted>
  <last_update_submitted_qc>July 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

